Replies to post #5281 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Re: Which partner?

>can you speculate on what companies might try to contract or partner with GTC to take advantage of their ADCC technology<

A new partnership in the FoB arena probably has to wait until the US regulatory pathway for FoB’s is established. It now looks like this won’t happen in 2007 (#msg-23650024).

I think the most likely partners for US ATryn commercialization are NVO and WYE (#msg-22008932). Regards, Dew